APA

Severson T. M., Wolf D. M., Yau C., Peeters J., Wehkam D., Schouten P. C., Chin S., Majewski I. J., Michaut M., Bosma A., Pereira B., Bismeijer T., Wessels L., Caldas C., Bernards R., Simon I. M., Glas A. M., Linn S. & van 't Veer L. (20180511). The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. : Breast cancer research : BCR.

Chicago

Severson Tesa M, Wolf Denise M, Yau Christina, Peeters Justine, Wehkam Diederik, Schouten Philip C, Chin Suet-Feung, Majewski Ian J, Michaut Magali, Bosma Astrid, Pereira Bernard, Bismeijer Tycho, Wessels Lodewyk, Caldas Carlos, Bernards René, Simon Iris M, Glas Annuska M, Linn Sabine and van 't Veer Laura. 20180511. The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. : Breast cancer research : BCR.

Harvard

Severson T. M., Wolf D. M., Yau C., Peeters J., Wehkam D., Schouten P. C., Chin S., Majewski I. J., Michaut M., Bosma A., Pereira B., Bismeijer T., Wessels L., Caldas C., Bernards R., Simon I. M., Glas A. M., Linn S. and van 't Veer L. (20180511). The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. : Breast cancer research : BCR.

MLA

Severson Tesa M, Wolf Denise M, Yau Christina, Peeters Justine, Wehkam Diederik, Schouten Philip C, Chin Suet-Feung, Majewski Ian J, Michaut Magali, Bosma Astrid, Pereira Bernard, Bismeijer Tycho, Wessels Lodewyk, Caldas Carlos, Bernards René, Simon Iris M, Glas Annuska M, Linn Sabine and van 't Veer Laura. The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. : Breast cancer research : BCR. 20180511.